1. 'Scaly' tattoo reactions: is treatment mandatory?. (1st April 2017) Authors: Lambertini, M.; Dika, E.; Ravaioli, G. M.; Chessa, M. A.; Traniello Gradassi, A.; Baraldi, C.; Fanti, P. A.; Patrizi, A. Journal: Clinical and experimental dermatology Issue: Volume 42:Number 3(2017) Page Start: 347 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 'Scaly' tattoo reactions: is treatment mandatory?. (27th February 2017) Authors: Lambertini, M.; Dika, E.; Ravaioli, G. M.; Chessa, M. A.; Traniello Gradassi, A.; Baraldi, C.; Fanti, P. A.; Patrizi, A. Journal: Clinical and experimental dermatology Issue: Volume 42:Number 3(2017) Page Start: 347 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1517 Emergency department as place of end-of-life care and death in cancer patients. (September 2015) Authors: Pronzato, P.; Casabona, F.; Lambertini, M.; Morganti, S.; Reggiani, S.; Zoli, D.; Orengo, G. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S209 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 1863 First line trastuzumab- or lapatinib-based therapy in her2-positive metastatic breast cancer patients after prior (neo)adjuvant trastuzumab. (September 2015) Authors: Vaglica, M.; Lambertini, M.; Ferreira, A.; Poggio, F.; Puglisi, F.; Sottotetti, F.; Montemurro, F.; Poletto, E.; Pozzi, E.; Risi, E.; Lai, A.; Zanardi, E.; Sini, V.; Ziliani, S.; Minuti, G.; Mura, S.; Grasso, D.; Ferrarini, I.; Pronzato, P.; Del Mastro, L. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S286 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 1957 Ovarian suppression with luteinizing hormone-releasing hormone agonists during chemotherapy as a strategy to preserve ovarian function and fertility in breast cancer patients: A systematic review and meta-analysis of randomized studies. (September 2015) Authors: Lambertini, M.; Ceppi, M.; Poggio, F.; Peccatori, F.A.; Azim, H.A.; Ugolini, D.; Pronzato, P.; Loibl, S.; Moore, H.C.F.; Partridge, A.H.; Del Mastro, L. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S318 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 237P Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: A joint analysis of OnCovid and ESMO-CoCARE registries. (December 2022) Authors: Cortellini, A.; Dettorre, G.; Dafni, U.; Aguilar Company, J.; Castelo-Branco, L.; Lambertini, M.; Gennatas, S.; Rogado, J.; Vinal Lozano, D.; Harrington, K.J.; Tsourti, Z.; Michielin, O.A.; Pommeret, F.; Brunet Vidal, J.M.; Tabernero, J.; Pentheroudakis, G.; Gennari, A.; Peters, S.; Romano, E.; P... Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 63P Activity and safety of first-line treatments for advanced melanoma: A network meta-analysis. (December 2022) Authors: A. Boutros, ; Tanda, E.T.; Croce, E.; Catalano, F.; Ceppi, M.; Bruzzone, M.; Cecchi, F.; Arecco, L.; Fraguglia, M.; Pronzato, P.; Del Mastro, L.; Lambertini, M.; Spagnolo, F. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A survey on physicians' knowledge, practice and attitudes on fertility and pregnancy issues in young breast cancer patients. (March 2017) Authors: Lambertini, M.; Di Maio, M.; Pagani, O.; Demeestere, I.; Del Mastro, L.; Loibl, S.; Partridge, A.H.; Azim, H.H.; Peccatori, F.A. Journal: Breast Issue: Volume 32(2017)Supplement 1 Page Start: S85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. A12First line trastuzumab- or lapatinib-based therapy in her2-positive metastatic breast cancer patients after prior (NEO)adjuvant trastuzumab. (26th September 2015) Authors: Vaglica, M.; Vaglica, M.; Lambertini, M.; Ferreira, A.; Poggio, F.; Puglisi, F.; Sottotetti, F.; Montemurro, F.; Poletto, E.; Pozzi, E.; Risi, E.; Lai, A.; Zanardi, E.; Sini, V.; Ziliani, S.; Minuti, G.; Mura, S.; Grasso, D.; Ferrarini, I.; Pronzato, P. Journal: Annals of oncology Issue: Volume 26(2015)Supplement 6 Page Start: vi6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Breast Cancer Patients' Experience and Wishes Regarding Communication on Sexual Health: The BEROSE Study. (3rd July 2022) Authors: Aupomerol, M.; Chaltiel, D.; Pautier, P.; Wehrer, D.; Véron, L.; Degousée, L.; Fasse, L.; Guéroult-Accolas, L.; Di Meglio, A.; Scotté, F.; De-Jesus, A.; Vaz-Luis, I.; Delaloge, S.; Lambertini, M.; Pistilli, B. Journal: Cancer investigation Issue: Volume 40:Number 6(2022) Page Start: 483 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗